Soltani, Fardad
Jenkins, David A.
Kaura, Amit
Bradley, Joshua
Black, Nicholas
Farrant, John P.
Williams, Simon G.
Mulla, Abdulrahim
Glampson, Benjamin
Davies, Jim
Papadimitriou, Dimitri
Woods, Kerrie
Shah, Anoop D.
Thursz, Mark R.
Williams, Bryan
Asselbergs, Folkert W.
Mayer, Erik K.
Herbert, Christopher
Grant, Stuart
Curzen, Nick
Squire, Iain
Johnson, Thomas
O’Gallagher, Kevin
Shah, Ajay M.
Perera, Divaka
Kharbanda, Rajesh
Patel, Riyaz S.
Channon, Keith M.
Lee, Richard
Peek, Niels
Mayet, Jamil
Miller, Christopher A.
Funding for this research was provided by:
NIHR Imperial Biomedical Research Centre
NIHR Oxford Biomedical Research Centre
NIHR University College London Biomedical Research Centre
National Institute for Health and Care Research (AI_AWARD01864, NIHR301338)
UK Research and Innovation (Horizon Europe Guarantee for DataTools4Heart)
British Heart Foundation (AA/18/6/24223, FS/CRA/22/23036, AA/18/4/34221)
NIHR Leeds Clinical Research Facility
NIHR Manchester Biomedical Research Centre
NIHR Southampton Biomedical Research Centre
NIHR Leicester Biomedical Research Centre
NIHR Bristol Biomedical Research Centre
British Heart Foundation Centre of Excellence at the School of Cardiovascular Medicine and Sciences, King’s College London
NIHR Biomedical Research Centre at The Royal Marsden and Institute of Cancer Research
BHF Imperial Centre for Research Excellence (RE/18/4/34215)
Article History
Received: 3 January 2024
Accepted: 19 June 2024
First Online: 5 July 2024
Declarations
:
: The study was approved by the NHS Health Research Authority London-South East Research Ethics Committee institutional review board (REC reference: 16/HRA/3327). The need for consent to participate was waived by the NHS Health Research Authority London-South East Research Ethics Committee. Informed consent was not obtained from any participant.
: Not applicable.
: CAM has participated on advisory boards/consulted for AstraZeneca, Boehringer Ingelheim and Lilly Alliance, Novartis and PureTech Health, serves as an advisor for HAYA Therapeutics, has received speaker fees from AstraZeneca, Boehringer Ingelheim and Novo Nordisk, conference attendance support from AstraZeneca, and research support from Amicus Therapeutics, AstraZeneca, Guerbet Laboratories Limited, Roche and Univar Solutions B.V.